{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:13:39Z","timestamp":1772662419606,"version":"3.50.1"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10006-019-00822-w","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T12:02:38Z","timestamp":1576756958000},"page":"239-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A primary cutaneous anaplastic large cell lymphoma mimicking labial herpes"],"prefix":"10.1007","volume":"24","author":[{"given":"Danielli Fernandes","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Scopel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Filipe","family":"da Paz Scardua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volmar Belis\u00e1rio","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Nascimento","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana Aparecida Pimenta","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Resende","family":"Camisasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-7955","authenticated-orcid":false,"given":"T\u00e2nia Regina Gr\u00e3o","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"822_CR1","unstructured":"Swerdlow, S. H. (Ed.). (2017). WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer"},{"issue":"12","key":"822_CR2","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","volume":"95","author":"MW Bekkenk","year":"2000","unstructured":"Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA et al (2000) Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95(12):3653\u20133661 PMID:10845893","journal-title":"Blood"},{"issue":"7","key":"822_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/modpathol.2012.38","volume":"25","author":"AP Sciallis","year":"2012","unstructured":"Sciallis AP, Law ME, Inwards DJ, McClure RF, Macon WR, Kurtin PJ et al (2012) Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol 25(7):983\u2013992. https:\/\/doi.org\/10.1038\/modpathol.2012.38","journal-title":"Mod Pathol"},{"key":"822_CR4","doi-asserted-by":"publisher","unstructured":"Meconi, F., Secchi, R., Palmieri, R., Vaccarini, S., Rapisarda, V. M., Giann\u00ec, L., ... & Cantonetti, M. (2019). Primary cutaneous anaplastic large cell lymphoma of the oral cavity successfully treated with brentuximab vedotin. Case reports in hematology, 2019. DOI:https:\/\/doi.org\/10.1155\/2019\/9651207","DOI":"10.1155\/2019\/9651207"},{"key":"822_CR5","doi-asserted-by":"publisher","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","DOI":"10.1182\/blood-2016-01-643569"},{"issue":"10168","key":"822_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","volume":"393","author":"S Horwitz","year":"2018","unstructured":"Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R et al (2018) Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet 393(10168):229\u2013240. https:\/\/doi.org\/10.1016\/S0140-6736(18)32984-2","journal-title":"Lancet"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-019-00822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10006-019-00822-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-019-00822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:21:19Z","timestamp":1608250879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10006-019-00822-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s10006-019-00822-w","relation":{},"ISSN":["1865-1550","1865-1569"],"issn-type":[{"value":"1865-1550","type":"print"},{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards, approved by the Ethics Committee under number 2.568.743.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient described in the case report. The patient consent form was approved by the Ethics Committee and assigned to the patient in the language understandable for him including accept to publish of images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}